AR003125A1 - Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la - Google Patents
Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en laInfo
- Publication number
- AR003125A1 AR003125A1 ARP960102670A AR10267096A AR003125A1 AR 003125 A1 AR003125 A1 AR 003125A1 AR P960102670 A ARP960102670 A AR P960102670A AR 10267096 A AR10267096 A AR 10267096A AR 003125 A1 AR003125 A1 AR 003125A1
- Authority
- AR
- Argentina
- Prior art keywords
- infections
- diagnosis
- helicobacter pylori
- proapily
- elepipetico
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 230000006798 recombination Effects 0.000 abstract 2
- 238000005215 recombination Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención se refiere a polipéptidos de recombinación que constituyen a los antígenos expuestos en superficie de Helicobacter pylori conun peso molecular aproximado de 29 kDa. La invención además provee moléculas de ácido nucleicoq ue codifican a dichos polipéptidos, así como también vectoresy células huésped que comprenden a estas moléculas de ácido nucleico. Dichos polipéptidos de recombinación son útiles para el diagnóstico de las infeccionespor H. pylori y para lafabric ación de composiciones para vacunas que desarrollan una respuesta inmune protectora contra estas infecciones, dichascomposiciones para vacunas son adecuadas tanto para uso terapéutico como para uso profiláctico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9502007A SE9502007D0 (sv) | 1995-06-01 | 1995-06-01 | Novel polypeptides |
SE9601085A SE9601085D0 (sv) | 1996-03-21 | 1996-03-21 | Novel polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AR003125A1 true AR003125A1 (es) | 1998-07-08 |
Family
ID=26662316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960102670A AR003125A1 (es) | 1995-06-01 | 1996-05-22 | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
Country Status (22)
Country | Link |
---|---|
US (2) | US6025164A (es) |
EP (1) | EP0828757A1 (es) |
JP (1) | JP3380559B2 (es) |
KR (1) | KR19990022131A (es) |
CN (1) | CN1191544A (es) |
AR (1) | AR003125A1 (es) |
BR (1) | BR9608627A (es) |
CA (1) | CA2222797A1 (es) |
CZ (1) | CZ357397A3 (es) |
EE (1) | EE9700306A (es) |
HU (1) | HUP9901546A3 (es) |
IL (1) | IL122340A0 (es) |
IS (1) | IS4615A (es) |
MY (1) | MY119003A (es) |
NO (1) | NO975490L (es) |
NZ (1) | NZ303356A (es) |
PL (1) | PL323741A1 (es) |
RU (1) | RU2195463C2 (es) |
SK (1) | SK155297A3 (es) |
TR (1) | TR199701471T1 (es) |
TW (1) | TW570925B (es) |
WO (1) | WO1996038475A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2682122B1 (fr) * | 1991-10-03 | 1995-06-09 | Pasteur Institut | Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori. |
JPH08509873A (ja) | 1993-05-19 | 1996-10-22 | アンスティテュ・パストゥール | ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列 |
US6258359B1 (en) | 1993-05-19 | 2001-07-10 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides |
US6406703B1 (en) | 1993-07-27 | 2002-06-18 | Csl Limited | Treatment of H. pylori associated gastroduodenal disease |
KR100333113B1 (ko) * | 1993-07-27 | 2002-11-27 | 시에스엘 리미티드 | 헬리코박터피롤리관련위십이지장질환의치료방법 |
AUPM612494A0 (en) * | 1994-06-08 | 1994-06-30 | Csl Limited | Treatment or prevention of helicobacter infection |
EE9700373A (et) * | 1995-06-07 | 1998-06-15 | Astra Aktiebolag | Helicobacter pyloriga seotud nukleiinhapete ja aminohapete järjestused diagnoosimiseks ja raviks |
EP0971734A4 (en) * | 1997-03-26 | 2001-02-07 | Avant Immunotherapeutics Inc | CARBOHYDRATE ANTIGENS HAVING IMMUNOLOGICAL REACTIVITY WITH POLYCLONAL ANTISERUMS AGAINST H. PYLORI |
CA2289253A1 (en) * | 1997-04-30 | 1998-11-05 | Merieux Oravax | Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method |
SE9702242D0 (sv) * | 1997-06-12 | 1997-06-12 | Astra Ab | Vaccine compositions V |
SE9702241D0 (sv) * | 1997-06-12 | 1997-06-12 | Astra Ab | Vaccine compositions IV |
US7393529B2 (en) * | 1998-04-09 | 2008-07-01 | Idexx Laboratories, Inc. | Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
SE9801288D0 (sv) * | 1998-04-14 | 1998-04-14 | Astra Ab | Vaccine delivery system and metod of production |
JP4346821B2 (ja) * | 1998-04-30 | 2009-10-21 | カイロン ソチエタ ア レスポンサビリタ リミタータ | H.Pyloriによる感染に対する免疫化および処置 |
AU3205000A (en) * | 1999-02-19 | 2000-09-04 | Astrazeneca Ab | Expression of helicobacter polypeptides in pichia pastoris |
GB9924351D0 (en) | 1999-10-14 | 1999-12-15 | Brennan Frank | Immunomodulation methods and compositions |
WO2001083531A1 (en) * | 2000-04-27 | 2001-11-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for identifying helicobacter antigens |
GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
US20020107368A1 (en) * | 2000-12-07 | 2002-08-08 | Jing-Hui Tian | Helicobacter proteins, gene sequences and uses thereof |
WO2005019249A2 (en) | 2003-08-15 | 2005-03-03 | University Of Florida | Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
US7381547B2 (en) * | 2004-04-28 | 2008-06-03 | Tzam Diagnostics, Llc | Methods and compositions to detect bacteria using multiplex PCR |
KR100613924B1 (ko) * | 2004-06-23 | 2006-08-21 | 현대자동차주식회사 | 자동차 연료 시스템 |
WO2007014179A2 (en) * | 2005-07-25 | 2007-02-01 | University Of Rochester | Method for controlling immunodominance |
WO2009014782A2 (en) * | 2007-04-27 | 2009-01-29 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
CN101496898B (zh) * | 2009-02-16 | 2011-06-15 | 中国人民解放军军事医学科学院生物工程研究所 | 一种预防和/或治疗幽门螺杆菌感染的疫苗 |
RU2449805C1 (ru) | 2011-01-27 | 2012-05-10 | Общество С Ограниченной Ответственностью "Гармония" | Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования |
US10828358B2 (en) | 2015-12-14 | 2020-11-10 | Technische Universität München | Helicobacter pylori vaccines |
US10577409B2 (en) * | 2016-05-26 | 2020-03-03 | Sagabio Co., Ltd. | Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody |
CN107456578A (zh) * | 2016-06-03 | 2017-12-12 | 硕英生医股份有限公司 | 一种关闭病原体的免疫抑制功能的方法及其用途 |
EP3272354A1 (en) | 2016-07-20 | 2018-01-24 | Technische Universität München | Agents and methods for the prevention or treatment of h. pylori infections |
CN111467368B (zh) * | 2020-04-13 | 2021-05-28 | 江南大学 | 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用 |
CN113144182B (zh) * | 2021-04-22 | 2023-03-10 | 成都欧林生物科技股份有限公司 | 一种幽门螺杆菌口服缓释疫苗及其制备与应用 |
CN113896775A (zh) * | 2021-08-25 | 2022-01-07 | 河北医科大学第四医院 | 幽门螺杆菌特异性免疫原性肽段 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0606921T3 (da) * | 1989-03-09 | 2000-09-04 | American Cyanamid Co | Fremgangsmåde til isolering af Haemophilus influenzae protein E |
US5721349A (en) * | 1992-02-26 | 1998-02-24 | Vanderbilt University | Vacuolating toxin-deficient H. pylori |
MX9301706A (es) * | 1992-04-13 | 1994-05-31 | Oravax Inc | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. |
US5420014A (en) * | 1992-04-30 | 1995-05-30 | Auspharm International Ltd. | Rapid in vitro test for helicobacter pylori using saliva |
-
1996
- 1996-05-22 AR ARP960102670A patent/AR003125A1/es unknown
- 1996-05-30 MY MYPI96002075A patent/MY119003A/en unknown
- 1996-06-03 TR TR97/01471T patent/TR199701471T1/xx unknown
- 1996-06-03 HU HU9901546A patent/HUP9901546A3/hu unknown
- 1996-06-03 CZ CZ973573A patent/CZ357397A3/cs unknown
- 1996-06-03 CN CN96195684A patent/CN1191544A/zh active Pending
- 1996-06-03 PL PL96323741A patent/PL323741A1/xx unknown
- 1996-06-03 US US08/669,560 patent/US6025164A/en not_active Expired - Fee Related
- 1996-06-03 BR BR9608627A patent/BR9608627A/pt not_active Application Discontinuation
- 1996-06-03 CA CA002222797A patent/CA2222797A1/en not_active Abandoned
- 1996-06-03 IL IL12234096A patent/IL122340A0/xx unknown
- 1996-06-03 SK SK1552-97A patent/SK155297A3/sk unknown
- 1996-06-03 KR KR1019970708610A patent/KR19990022131A/ko not_active Application Discontinuation
- 1996-06-03 JP JP53641496A patent/JP3380559B2/ja not_active Expired - Fee Related
- 1996-06-03 WO PCT/SE1996/000727 patent/WO1996038475A1/en not_active Application Discontinuation
- 1996-06-03 RU RU98100200/13A patent/RU2195463C2/ru not_active IP Right Cessation
- 1996-06-03 EP EP96917779A patent/EP0828757A1/en not_active Withdrawn
- 1996-06-03 EE EE9700306A patent/EE9700306A/xx unknown
- 1996-08-20 TW TW085110165A patent/TW570925B/zh active
- 1996-12-05 NZ NZ303356A patent/NZ303356A/en unknown
-
1997
- 1997-11-17 IS IS4615A patent/IS4615A/is unknown
- 1997-11-28 NO NO975490A patent/NO975490L/no not_active Application Discontinuation
-
1999
- 1999-09-15 US US09/396,975 patent/US20020168726A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IS4615A (is) | 1997-11-17 |
EP0828757A1 (en) | 1998-03-18 |
AU703331B2 (en) | 1999-03-25 |
KR19990022131A (ko) | 1999-03-25 |
CZ357397A3 (cs) | 1998-05-13 |
PL323741A1 (en) | 1998-04-14 |
NO975490D0 (no) | 1997-11-28 |
CA2222797A1 (en) | 1996-12-05 |
WO1996038475A1 (en) | 1996-12-05 |
HUP9901546A2 (hu) | 1999-08-30 |
MX9709194A (es) | 1998-07-31 |
SK155297A3 (en) | 1998-08-05 |
RU2195463C2 (ru) | 2002-12-27 |
IL122340A0 (en) | 1998-04-05 |
BR9608627A (pt) | 1999-06-15 |
EE9700306A (xx) | 1998-06-15 |
US6025164A (en) | 2000-02-15 |
TR199701471T1 (xx) | 1998-02-21 |
AU6020596A (en) | 1996-12-18 |
NO975490L (no) | 1998-01-07 |
NZ303356A (en) | 1999-05-28 |
JPH11507210A (ja) | 1999-06-29 |
HUP9901546A3 (en) | 2003-07-28 |
MY119003A (en) | 2005-03-31 |
CN1191544A (zh) | 1998-08-26 |
TW570925B (en) | 2004-01-11 |
US20020168726A1 (en) | 2002-11-14 |
JP3380559B2 (ja) | 2003-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR003125A1 (es) | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la | |
CY1121353T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
BR9712852A (pt) | Plasmìdeo, composição, processo de imunização de um indivìduo contra um patógeno, vacina recombinante, patógeno vivo atenuado, proteìna bl-1 substancialmente pura, vetor recombinante de expressão, e, anticorpo isolado | |
BR9712971A (pt) | Método para produção de uma vacina para proteção de um hospedeiro contra doença causada com uma cadeia de chlamydia e composição imunológica | |
BR0210216A (pt) | Holotoxina do cólera imunogênica, mutante (ct-crm), composição imunogênica, métodos para aumentar a resposta imune de um hospedeiro vertebrado a um antìgeno, e para produzir uma holotoxina do cólera imunogênica, mutante, sequência ou molécula de ácido nucleico isolado e purificado, célula hospedeira, e, uso de uma holotoxina do cólera mutante | |
IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
FI102382B1 (fi) | Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten | |
BR9914777A (pt) | Moléculas isoladas de ácido nucléico que codificam os fatores induzìveis por células t (tifs), as proteìnas codificadas e os usos das mesmas | |
AR006999A1 (es) | Una composición inmunogénica, terapéutica o profiláctica , que comprende un polipéptido omp106 aislado, un anticuerpo aislado que se liga a dicho polipéptido y una vacuna que lo comprende. | |
BR9712556A (pt) | Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno | |
BRPI0314373B8 (pt) | produto imunogênico estável para a indução de anticorpos contra uma ou várias proteínas antigênicas em um indivíduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
HK1073064A1 (en) | Means for improving immune response | |
AR004341A1 (es) | Vacunas contra tumores y procedimiento para su produccion. | |
DE69737413D1 (en) | Bakterioferritin aus helicobacter pylori | |
DE69515340T2 (de) | Impfstoff gegen mycobakterielle infektionen | |
DE602004028029D1 (en) | Rwendung | |
AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
BR9608894A (pt) | Produtos extracelulares abundantes e processos para suas producões e usos | |
DK1290160T3 (da) | Humane Pellino-polypeptider | |
BR9710849A (pt) | Vacina contendo uma peróxi-redoxina e/ou uma beta-tubulina. | |
SE9604296D0 (sv) | New pharmaceutical formulation of polypeptides | |
ATE283065T1 (de) | Mehrzweckvakzine gegen umhüllte viren | |
MXPA03010527A (es) | Composicion de vacuna. | |
ATE160377T1 (de) | Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren | |
DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus |